Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1007 of 1,261
  1. US 7692008

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  2. US 7691567

    Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin

    The Board of Regents of the University of Texas System · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  3. US 7687610

    Human chorionic gonadotropin superagonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  4. US 7687521

    Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  5. US 7687500

    Substituted oxetanes, method of making, and method of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  6. US 7687638

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  7. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  8. US 7687642

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  9. US 7687506

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  10. US 7687622

    Process for preparing quetiapine fumarate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  11. US 7687660

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  12. US 7687462

    Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition

    The Regents of the University of California · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  13. US 7687519

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  14. US 7687480

    Phosphonate compounds

    The Regents of the University of California · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  15. US 7687481

    Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Jenrin Discovery, LLC · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  16. US 7687625

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  17. US 7683173

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  18. US 7683082

    1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  19. US 7683080

    Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  20. US 7683095

    Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  21. US 7683083

    Biphenyl derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  22. US 7683066

    Isoquinolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  23. US 7683188

    Process for preparation of mycophenolic acid and ester derivatives thereof

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  24. US 7683065

    Pyridines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.